Carl Zeiss Meditec

Healthcare & biotech / Medical Devices and Healthcare Technology

🚀 Founded 2002 🌎 Germany 🏷️ CZMWF DE0005313704 ⭐ 3000 DCF 28.42 💰67.23

ℹ️ Info

🧾 At a Glance 📎 Core Facts 🛍️ Products/Services ⭐ Ratings 🧑‍💼 Executives 💬 My Comments

💡 Analytics

🔔 Insights 🏢 Company Q&A (464) 🛠️ Industry Q&A (98) 🏁 Competitors 📊 Price Low 📈 Price Swings ⚡ SWOT 🏛️ PEST 🌀 Porter's Five Forces ✨ Score Positive ⚠️ Risk Assessment 🧩 Segmentation 🅶 Google Links

💸 Financials

⚖️ Balance Sheet 💵 Income Statement 🔄 Cash Flow 👑 Owner Earnings

📊 Ratios

💰 Margins 📐 Financial Ratios 🌱 Growth 📏 Enterprise Value 📌 Key Metrics 💵 Dividends

🔧 Tools

✅ Due Diligence

📚 Resources

📰 News 🔶 Clusters 🗂️ SEC Filings 🔢 Stock Split History 📢 Press Releases 👤 Insider Trades 📅 Earnings Calendar 🌐 Web 📝 Reports

📢 Press Releases

[ Disclaimer ]

Date	Press release
2023-12-15 13:58:00	Carl Zeiss Meditec Ag Announces Agreement To Acquire Dutch Ophthalmic Research Center (d.o.r.c.) Acquisition will extend the company’s leadership in ophthalmic medical devices market and expands its position in the vitreo-retinal surgery segment jena, germany , dec. 15, 2023 /prnewswire/ -- carl zeiss meditec ag announced today that it has entered into an agreement to acquire 100% of the shares in dutch ophthalmic research center (international) b.v. (d.o.r.c.) from the investment firm eurazeo se, paris, france.

Date

Press release

2023-12-15 13:58:00

Carl Zeiss Meditec Ag Announces Agreement To Acquire Dutch Ophthalmic Research Center (d.o.r.c.)
Acquisition will extend the company’s leadership in ophthalmic medical devices market and expands its position in the vitreo-retinal surgery segment jena, germany , dec. 15, 2023 /prnewswire/ -- carl zeiss meditec ag announced today that it has entered into an agreement to acquire 100% of the shares in dutch ophthalmic research center (international) b.v. (d.o.r.c.) from the investment firm eurazeo se, paris, france.

📰 Browse additional press releases for Carl Zeiss Meditec!

🙌 Join now to get "The Checklist Value Investor — A Smarter Way to Pick Stocks" at no cost

What is special about us?

Newsletter

Imprint

Disclaimer

×
Disclaimer

InsightfulValue is an independent platform dedicated to value investing research. The information provided on this website is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice.
We are not financial advisors, investment consultants, or licensed consultants. Our analyses, insights, and criteria are based on principles learned from renowned value investors such as Benjamin Graham, Warren Buffett, and Charlie Munger, but they should not be considered personalized investment recommendations.
Investing in financial markets carries risks, and past performance is not indicative of future results. Users of this website should conduct their own due diligence and consult with a qualified professional before making any financial or investment decisions. InsightfulValue assumes no liability for any financial losses or decisions made based on the information provided on this site.
By using this website, you acknowledge and accept that all investments involve risk and that InsightfulValue does not guarantee any financial outcomes.

Legal

Due Diligence

To start evaluating the companies of your choice, sign up or log in.